Aura Biosciences Inc
Aura Biosciences Inc (AURA) Covered Calls
Aura Biosciences Inc trades in the Biotechnology industry with an IV Rank of 65.08%, average versus the past year. AURA's highest covered call setup is the $8.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 5.12% out of the money with 9 days to expiration, a 5.78% return until expiration, and a 234.49% theoretical annualized return. Across the setups shown, annualized returns run from 15.07% to 234.49% at strikes between $8.00 and $8.00, with 9 to 156 days to expiration, as of Nov 11, 2026.
Read more
Running AURA covered calls helps you generate income from Aura Biosciences Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best AURA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If AURA stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling AURA covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given AURA covered call is worth writing.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
| 2026-11-20 | 9 | 8.00 | 5.12 | 0.05 | 4.20 | 44.00 | 5.78 | 234.49 | -0.66 | +0.62 | 0 | 4.15 |
| 2027-04-16 | 156 | 8.00 | 5.12 | 0.10 | 4.90 | 49.00 | 6.44 | 15.07 | -1.31 | +0.66 | 0 | 4.80 |
As of Nov 11, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank65.08% Moderate
- Market cap (M$)740
- 52 weeks high-25.47%
- 52 weeks low50.32%
- Analyst recommendationStrong Buy
1.00 - Target price$16.60
133.47% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-1.67
- EPS growth next 5 years14.24%
As of Nov 13, 2026